Physician profile
Michael E Le
NPI 1821350059
$26,997.86
in general payments reported to CMS, 2019-2025
26 companies · $4,464 in 2025
The $4,464 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,878 · 2020: $4,120 · 2021: $8,456 · 2022: $2,910 · 2023: $1,376 · 2024: $3,794 · 2025: $4,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,736 · Food and Beverage: $3,958 · Consulting Fee: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,736.37 |
| Food and Beverage | $3,957.78 |
| Consulting Fee | $940.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $7,322.98 | 2021 | |
| Stryker Corporation | $7,209.79 | 2021-2025 | Infinity, Inbone, Ortholoc 2 Lapifuse |
| Medical Device Business Services, INC. | $4,742.70 | 2019-2025 | Motoband |
| Wright Medical Technology, INC. | $2,247.60 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,539.21 | 2019-2025 | Rosa, Avenir |
| Depuy Synthes Sales INC. | $1,260.42 | 2019-2025 | Hammerlock, Crosstie, Motoband |
| Avanos Medical | $751.46 | 2020-2022 | |
| Abbott Laboratories | $387.44 | 2019-2025 | Eterna |
| Smith+Nephew, INC. | $308.94 | 2019-2025 | Na, Bone Anchors With Arthroscopic Delivery System, Grafix Pl |
| Medshape, INC. | $300.00 | 2020 | |
| Flower Orthopedics Coporation | $184.02 | 2024 | |
| Osteoremedies, LLC | $150.56 | 2020 | |
| Sanara Medtech INC. | $145.35 | 2024 | Celleraterx |
| Medline Industries LP | $134.24 | 2021 | |
| Peerless Surgical INC. | $91.12 | 2019-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $40.92 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Osiris Therapeutics INC. | $37.06 | 2019 | |
| Horizon Therapeutics Plc | $27.01 | 2019-2021 | |
| Baxter Healthcare | $22.95 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.36 | 2021 | |
| Nalu Medical, INC. | $16.34 | 2023 | Nalu Neurostimulation System |
| Paragon 28, INC. | $16.22 | 2020 | |
| Ermi LLC | $16.14 | 2019 | |
| Bioventus LLC | $15.76 | 2022 | |
| Kci USA, INC. | $13.27 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$12,486.98 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.